CAS: 139122-81-9 - tripterifordin
Fórmula:C20H30O3
InChI:InChI=1S/C20H30O3/c1-17-7-3-8-20(12-23-16(17)21)14(17)6-9-19-10-13(4-5-15(19)20)18(2,22)11-19/h13-15,22H,3-12H2,1-2H3/t13-,14-,15-,17-,18-,19+,20+/m1/s1
Clave InChI:InChIKey=KLMZPLYXGZZBCX-CJSYXLNHSA-N
SMILES:O=C1OCC23CCCC1(C)C3CCC45CC(CCC42)C(O)(C)C5
- Sinónimos:
- (8Alpha,10Alpha,13Alpha,16Beta)-16-Hydroxy-18,20-Epoxykauran-18-One
- (8Alpha,9Xi,10Alpha,13Alpha,16Beta)-16-Hydroxy-18,20-Epoxykauran-18-One
- 1H,3H-6a,9-Methano-4,11b-propanocyclohepta[h][2]benzopyran, kauran-18-oic acid deriv.
- Antriptolactone
- Hydroxyodolide
- Hypodiolide A
- Kauran-18-oic acid, 16,20-dihydroxy-, delta-lactone, (4alpha)-
- Kauran-18-oic acid, 16,20-dihydroxy-, δ-lactone, (4α)-
Kauran-18-oic acid, 16,20-dihydroxy-, δ-lactone, (4α)-
CAS:139122-81-9
Fórmula:
C20H30O3
Pureza:
95%+
Forma y color:
Solid
Peso molecular:
318.4504
Ref: IN-DA001ACL
5mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
Ref: 7W-GY8745
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 3 de Enero de 2025
Ref: BP-BP1410
10mg | 166,00 € | ||
20mg | 248,00 € | ||
100mg | 730,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Tripterifordin
CAS:139122-81-9
Tripterifordin shows anti-HIV replication activity in H9 lymphocyte cells with an EC50 of 1 microgram/ml.
Fórmula:
C20H30O3
Pureza:
95% - 99.46%
Forma y color:
Solid
Peso molecular:
318.45
Ref: TM-TN2283
1mg | 98,00 € | ||
5mg | 291,00 € | ||
10mg | 416,00 € | ||
25mg | 622,00 € | ||
50mg | 842,00 € | ||
100mg | 1.082,00 € | ||
200mg | 1.495,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025
Tripterifordin
CAS:139122-81-9
Tripterifordin is a monoclonal antibody that binds to protease activity and inhibits the action of …
Fórmula:
C20H30O3
Pureza:
Min. 95%
Peso molecular:
318.46 g/mol
Ref: 3D-PFA12281
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Febrero de 2025